Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Belém, Brazil
- PMID: 25921710
- DOI: 10.1016/j.oooo.2015.03.008
Oral carriage of Candida species in HIV-infected patients during highly active antiretroviral therapy (HAART) in Belém, Brazil
Abstract
Objective: To identify the oral carriage of Candida spp in patients infected by human immunodeficiency virus (HIV) and the possible correlation with clinical characteristics.
Study design: Mucosal swab samples collected from 246 patients who were infected by HIV, did not have oral candidiasis, and were being treated with highly active antiretroviral therapy were analyzed. Yeast colonies that developed were identified by using the VITEK 2 automated system.
Results: Candida yeasts were present in 41.87% of the samples, and Candida albicans was the most prevalent (32.52%). Other identified Candida species were C tropicalis (4.88%), C parapsilosis (2.85%), C dubliniensis (0.81%), and C famata (0.81%).
Conclusions: There was low rate of oral Candida carriage in patients infected by HIV who were on highly active antiretroviral therapy. A greater prevalence of C albicans than non-albicans Candida species was found at the species level. Prior candidiasis predicted the oral carriage of C albicans; however, it did not influence the carriage of non-albicans species. This is the first report of oral carriage of C famata in patients with HIV infection.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.J Oral Pathol Med. 2010 Feb;39(2):188-94. doi: 10.1111/j.1600-0714.2009.00857.x. Epub 2009 Dec 22. J Oral Pathol Med. 2010. PMID: 20040023
-
Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.J Oral Pathol Med. 2014 Oct;43(9):696-703. doi: 10.1111/jop.12192. Epub 2014 Jun 14. J Oral Pathol Med. 2014. PMID: 24931443
-
Oral Candida carriage and immune status in Thai human immunodeficiency virus-infected individuals.J Med Microbiol. 2014 May;63(Pt 5):753-759. doi: 10.1099/jmm.0.069773-0. Epub 2014 Mar 3. J Med Microbiol. 2014. PMID: 24591706
-
Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.Int J STD AIDS. 2015 Aug;26(9):625-32. doi: 10.1177/0956462414548906. Epub 2014 Aug 25. Int J STD AIDS. 2015. PMID: 25156369 Review.
-
Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.Dis Mon. 2021 Sep;67(9):101169. doi: 10.1016/j.disamonth.2021.101169. Epub 2021 Feb 25. Dis Mon. 2021. PMID: 33640178 Review.
Cited by
-
Distribution and antifungal susceptibility profiles of Candida species isolated from people living with HIV/AIDS in a public hospital in Goiânia, GO, Brazil.Braz J Microbiol. 2023 Mar;54(1):125-133. doi: 10.1007/s42770-022-00851-w. Epub 2022 Nov 12. Braz J Microbiol. 2023. PMID: 36371517 Free PMC article.
-
Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth.Front Microbiol. 2019 May 31;10:1188. doi: 10.3389/fmicb.2019.01188. eCollection 2019. Front Microbiol. 2019. PMID: 31231324 Free PMC article.
-
Sensitization of Candida albicans to terbinafine by berberine and berberrubine.Biomed Rep. 2016 Apr;4(4):449-452. doi: 10.3892/br.2016.608. Epub 2016 Feb 23. Biomed Rep. 2016. PMID: 27073630 Free PMC article.
-
Biofilm-Producing Candida Species Causing Oropharyngeal Candidiasis in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal.HIV AIDS (Auckl). 2020 Jun 15;12:211-220. doi: 10.2147/HIV.S255698. eCollection 2020. HIV AIDS (Auckl). 2020. PMID: 32606995 Free PMC article.
-
Epidemiology, prevalence, and associated factors of oral candidiasis in HIV patients from southwest Iran in post-highly active antiretroviral therapy era.Front Microbiol. 2022 Sep 2;13:983348. doi: 10.3389/fmicb.2022.983348. eCollection 2022. Front Microbiol. 2022. PMID: 36118210 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous